FirstString Research Raises Over $26M in Series D Financing

May 1, 2021

FirstString Research (FirstString) has completed a Series D financing round, raising > $26 million. This Series D was led by Park West Asset Management, LLC (Park West) and included additional capital from new as well as existing investors/funds.

Tony Bartsh, Chairman of FirstString’s Board of Directors and partner at Park West said the following regarding the financing round: “Since Park West first invested in FirstString in 2018, the Company has rapidly advanced several programs into pivotal studies in areas where there is no FDA approved drug and high unmet need. These programs have substantial market opportunity, and we look forward to the read-out of the pivotal studies.”